Wei Chen

Wei Chen has extensive work experience in the biotechnology and pharmaceutical industry. From March 2020 to January 2022, Wei Chen worked at Allorion Therapeutics, initially as the Director and Head of Early Drug Discovery, and later promoted to Senior Director and Head of Translation Biology. Prior to Allorion Therapeutics, Wei Chen worked at Novartis Institutes for BioMedical Research (NIBR) from March 2009 to November 2019. At NIBR, Wei Chen held the positions of Principal Scientist I and II in Oncology Translational Research.

Wei Chen attended Chengdu University where they earned a Bachelor's degree in Biochemistry. After that, they went on to pursue a Master's degree at Harvard University in the field of Biochemistry and Molecular Biology. No specific start or end years for either degree are provided.